Genetic, epidemiological, and clinical aspects of hereditary pancreatitis: A population-based cohort study in Denmark

American Journal of Gastroenterology

Volumn 105, Issue 8, 2010, Pages 1876-1883

  Joergensen, Maiken Thyregod ^a   Brusgaard, Klaus ^a   Crüger, Dorthe Gylling ^b   Gerdes, Anne Marie ^a   Schaffalitzky De Muckadell, Ove B ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b LILLEBAELT HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; SERINE PROTEINASE INHIBITOR; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CANCER DIAGNOSIS; DENMARK; ENDOCRINE DISEASE; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC DISORDER; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PANCREATITIS; PRIORITY JOURNAL;

ADULT; CARRIER PROTEINS; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DENMARK; FEMALE; GENOTYPE; HUMANS; MALE; MUTATION; PANCREATIC NEOPLASMS; PANCREATITIS; PEDIGREE; POISSON DISTRIBUTION; PROGNOSIS; REGISTRIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; TRYPSIN;

EID: 77955422140     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.193     Document Type: Article

References (29)

1. Comfort MW, Steinberg AG. Pedigree of a family with hereditary chronicrelapsing pancreatitis. Gastroenterology 1952; 21: 54-63.
2. Whitcomb DC, Preston RA, Aston CE et al. A gene for hereditary pancreatitismaps to chromosome 7q35. Gastroenterology 1996; 110: 1975-1980
3. Brand RE, Lerch MM, Rubinstein WS et al. Advances in counselling andsurveillance of patients at risk for pancreatic cancer. Gut 2007; 56: 1460-1469
4. Howes N, Lerch MM, Greenhalf W et al. Clinical and genetic characteristics ofhereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2004; 2: 252-261
5. Lowenfels AB, Maisonneuve P, Whitcomb DC. Risk factors for cancer inhereditary pancreatitis. International Hereditary Pancreatitis Study Group.Med Clin North Am 2000; 84: 565-573
6. Witt H, Luck W, Hennies HC et al. Mutations in the gene encoding the serineprotease inhibitor, Kazal type 1 are associated with chronic pancreatitis.Nat Genet 2000; 25: 213-216
7. Sharer N, Schwarz M, Malone G et al. Mutations of the cystic fibrosis genein patients with chronic pancreatitis. N Engl J Med 1998; 339: 645-652
8. Weiss FU, Simon P, Bogdanova N et al. Complete cystic fibrosis transmembraneconductance regulator gene sequencing in patients with idiopathicchronic pancreatitis and controls. Gut 2005; 54: 1456-1460
9. De BK, Weren M, Proesmans M et al. Pancreatitis among patients withcystic fibrosis: correlation with pancreatic status and genotype. Pediatrics2005; 115: e463-9.
10. Bobadilla JL, Macek M Jr, Fine JP et al. Cystic fibrosis: a worldwide analysisof CFTR mutations\correlation with incidence data and application toscreening. Hum Mutat 2002; 19: 575-606.
11. Zielenski J, Tsui LC. Cystic fibrosis: genotypic and phenotypic variations.Annu Rev Genet 1995; 29: 777-807.
12. Rinderknecht H. Pancreatic secretory enzymes. In Go VLW, Dimagno EP,Gardner JD, Lebenthal E, Reber HA, Scheele GA (eds). The Pancreas:Biology, Pathology and Disease. Raven: New York, 1993, 219-251
13. Th readgold J, Greenhalf W, Ellis I et al. The N34S mutation of SPINK1(PSTI) is associated with a familial pattern of idiopathic chronic pancreatitisbut does not cause the disease. Gut 2002; 50: 675-681
14. Pfutzer RH, Barmada MM, Brunskill AP et al. SPINK1/PSTI polymorphismsact as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000; 119: 615-623
15. Chen JM, Mercier B, Audrezet MP et al. Mutations of the pancreaticsecretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis.Gastroenterology 2001; 120: 1061-1064
16. Gurusamy KS, Farouk M, Tweedie JH. UK guidelines for management ofacute pancreatitis: is it time to change? Gut 2005; 54: 1344-1345
17. Toouli J, Brooke-Smith M, Bassi C et al. Guidelines for the management ofacute pancreatitis. J Gastroenterol Hepatol 2002; 17 (Suppl): S15-39.
18. Layer P, Yamamoto H, KalthoffL et al. The different courses of early-andlate-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology1994; 107: 1481-1487
19. Witt H, Luck W, Becker M. A signal peptide cleavage site mutation in thecationic trypsinogen gene is strongly associated with chronic pancreatitis.Gastroenterology 1999; 117: 7-10.
20. Pfützer RH, Whitcomb DC. Trypsinogen mutations in chronic pancreatitis.Gastroenterology 1999; 117: 1507-1508
21. Weiss FU, Simon P, Witt H et al. SPINK1 mutations and phenotypic expressionin patients with pancreatitis associated with trypsinogen mutations.J Med Genet 2003; 40: e40.
22. Lankisch PG. The problem of diagnosing chronic pancreatitis. Dig LiverDis 2003; 35: 131-134
23. Copenhagen Pancreatitis Study. An interim report from a prospectiveepidemiological multicentre study. Scand J Gastroenterol 1981; 16: 305-312
24. Worning H. Exocrine pancreatic function in dyspepsia. Digestion1987; 37: 3-13.
25. Applebaum-Shapiro SE, Finch R, Pfützer RH et al. Hereditary pancreatitisin North America: the Pittsburgh-Midwest Multi-Center Pancreatic StudyGroup Study. Pancreatology 2001; 1: 439-443
26. Eland IS, Sturkenboom MJ, Wilson JH et al. Incidence and mortality of acutepancreatitis between 1985 and 1995. Scand J Gastroenterol 2000; 35: 1110-1116
27. Th omson SR, Hendry WS, McFarlane GA et al. Epidemiology and outcomeof acute pancreatitis. Br J Surg 1987; 74: 398-401.
28. Teich N, Schulz HU, Witt H et al. N34S, a pancreatitis associated SPINK1mutation, is not associated with sporadic pancreatic cancer. Pancreatology2003; 3: 67-68
29. Maisonneuve P, Marshall BC, Lowenfels AB. Risk of pancreatic cancer inpatients with cystic fibrosis. Gut 2007; 56: 1327-1328